RESUMEN
ABSTRACT: Tranexamic acid is an inexpensive antifibrinolytic treatment that reduces morbidity and mortality in civilian and military trauma patients. It must be administered within 3 hours of the injury, and its efficacy is greater the earlier it is given. It is already used preventively in the civilian environment in a number of indications to reduce bleeding and bleeding-related mortality. We wondered about the potential benefits of preventive oral administration of tranexamic acid prior to an assault for military personnel with a potential risk of injury.
Asunto(s)
Antifibrinolíticos , Hemorragia , Personal Militar , Ácido Tranexámico , Ácido Tranexámico/administración & dosificación , Ácido Tranexámico/uso terapéutico , Humanos , Antifibrinolíticos/administración & dosificación , Administración Oral , Hemorragia/prevención & control , Hemorragia/inducido químicamente , Heridas y Lesiones/complicacionesAsunto(s)
Hemocromatosis , Hemocromatosis/diagnóstico , Hemocromatosis/genética , Hemocromatosis/terapia , Humanos , HierroRESUMEN
Acute myocardial infarction (MI) affects mainly men. In women, chest pain is less typical, delaying the diagnosis and increasing the time before treatment is delivered. Morbidity-mortality is greater notably due to a modification of the myocardial reperfusion strategy. The acute care of MI is almost identical for men and women. Knowing more about the epidemiology of women with MI enables prevention strategies to be targeted.